Original Research
Accepted on 28 Jan 2026
Nerandomilast attenuates idiopathic inflammatory myopathy-associated interstitial lung disease via inhibiting proliferation and differentiation of B cells
in Inflammation
Original Research
Accepted on 28 Jan 2026
in Inflammation
Original Research
Published on 28 Jan 2026
in Inflammation
Review
Published on 28 Jan 2026
in Inflammation
Original Research
Published on 28 Jan 2026
in Inflammation
Original Research
Published on 28 Jan 2026
in Inflammation
Correction
Published on 28 Jan 2026
in Inflammation
Review
Published on 28 Jan 2026
in Inflammation
Original Research
Accepted on 27 Jan 2026
in Inflammation
Original Research
Accepted on 27 Jan 2026
in Inflammation
Original Research
Accepted on 27 Jan 2026
in Inflammation
Correction
Accepted on 27 Jan 2026
in Inflammation
Review
Accepted on 27 Jan 2026
in Inflammation
Original Research
Accepted on 27 Jan 2026
in Inflammation
Correction
Accepted on 27 Jan 2026
in Inflammation
Review
Accepted on 27 Jan 2026
in Inflammation
Review
Accepted on 27 Jan 2026
in Inflammation
Original Research
Accepted on 27 Jan 2026
in Inflammation
Original Research
Published on 27 Jan 2026
in Inflammation
Original Research
Published on 27 Jan 2026
in Inflammation
Original Research
Published on 27 Jan 2026
in Inflammation
Original Research
Published on 27 Jan 2026
in Inflammation
Systematic Review
Published on 27 Jan 2026
in Inflammation
Original Research
Published on 27 Jan 2026
in Inflammation
Original Research
Published on 27 Jan 2026
in Inflammation